Skip to main content

Year: 2022

International Petroleum Corporation Announces Intention to Renew Normal Course Issuer Bid

International Petroleum Corporation (“IPC” or the “Corporation”) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that it has sought approval from the Toronto Stock Exchange (the “TSX”) to renew its normal course issuer bid (the “NCIB”) to repurchase its own common shares (the “Common Shares”) through the facilities of the TSX, Nasdaq Stockholm and/or alternative Canadian trading systems. The IPC Board of Directors has approved, subject to acceptance by the TSX, the purchase of up to approximately 9.3 million Common Shares, representing approximately 6.8% of IPC’s issued and outstanding Common Shares (or 10% of IPC’s “public float” (as defined in the TSX Company Manual) as at November 24, 2022), to commence over a period of twelve months from December...

Continue reading

NOTICE ON APPROVAL OF PROSPECTUS SECOND SUPPLEMENT

UAB “Orkela”, legal entity code 304099538, registered address at Jogailos str. 4, Vilnius, the Republic of Lithuania (the Issuer). The terms with the first capital letter used in this Notice shall have the meanings given to them in the Issuer’s Prospectus approved by the Bank of Lithuania and published on 24 May 2022 (the Prospectus), unless stated otherwise in this Notice. The Issuer would like to inform you that on 22 November 2022 the Bank of Lithuania has approved the second supplement to the Prospectus (the Second Supplement). The Second Supplement was prepared following the Issuer’s decision to replace the Lead Manager and change the relevant information in the Prospectus, also to update the Offering schedule provided in the Prospectus. Each amendment to the Prospectus introduced under the Second Supplement is briefly explained in...

Continue reading

International Petroleum Corporation Announces Intention to Renew Normal Course Issuer Bid

TORONTO, Nov. 24, 2022 (GLOBE NEWSWIRE) — International Petroleum Corporation (“IPC” or the “Corporation”) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that it has sought approval from the Toronto Stock Exchange (the “TSX”) to renew its normal course issuer bid (the “NCIB”) to repurchase its own common shares (the “Common Shares”) through the facilities of the TSX, Nasdaq Stockholm and/or alternative Canadian trading systems. The IPC Board of Directors has approved, subject to acceptance by the TSX, the purchase of up to approximately 9.3 million Common Shares, representing approximately 6.8% of IPC’s issued and outstanding Common Shares (or 10% of IPC’s “public float” (as defined in the TSX Company Manual) as at November 24, 2022), to commence...

Continue reading

Arrival Announces Mr. F. Peter Cuneo Appointed as Interim CEO; Mr. Denis Sverdlov Appointed as Chairman of the Board; Departure of Mr. Avinash Rugoobur as President and Chief of Strategy; Mr. Rexford Tibbens Appointed as Chairman of the Strategic Planning and Operations Committee

LUXEMBOURG, Nov. 24, 2022 (GLOBE NEWSWIRE) — Arrival (NASDAQ: ARVL) (the “Company”), announces that Mr. F. Peter Cuneo has been appointed as Interim Chief Executive Officer. Mr. Cuneo stated, “I intend to bring the full depth of my experience to this operational role, ensuring that the Company executes on its next set of strategic goals. I look forward to working closely with Denis, the rest of the Board and our employees for the benefit of all Arrival’s stakeholders.” Mr. Denis Sverdlov is concurrently stepping down from his role as Chief Executive Officer and has been appointed as Chairman of the Board in the place of Mr. Cuneo who has resigned from the Board and the Audit Committee in order to focus on his duties as Interim CEO. Mr. Cuneo will continue to attend Board meetings as an observer. Mr. Sverdlov stated, “I am more...

Continue reading

MAX Power Reviewing Lithium Opportunities

VANCOUVER, British Columbia, Nov. 24, 2022 (GLOBE NEWSWIRE) — MAX Power Mining Corp. (CSE: MAXX) (“MAX Power” or the “Company”) is pleased to report that the Company is actively reviewing opportunities to acquire or develop projects in the lithium industry. This may include acquisition of lithium properties and or technologies and processes related to lithium extraction. The Company is in the advanced stages of negotiations for specific projects. Mr. Rav Mlait, CEO of MAX Power, commented: “Lithium is a key ingredient in batteries, which are integral components of next-generation automobiles, airplanes, electronic devices and grid energy storage. There is tremendous supply shortage and increasing demand reality that needs to be met over the several years and beyond. We have undertaken a review of properties and technological processes...

Continue reading

Azucar Reports Drilling Results from Lithocap Target, El Cobre Project, Mexico

El Cobre Property Target MapVANCOUVER, British Columbia, Nov. 24, 2022 (GLOBE NEWSWIRE) —  Azucar Minerals Ltd. (“Azucar” or the “Company”) (TSX-V: AMZ; OTCQB: AXDDF) is pleased to announce that it has received and compiled results from the two holes completed into the large lithocap target first discussed in its press release of March 10, 2022. Both holes passed through typical clay dominant lithocap alteration into phyllic alteration. Large intervals of brecciated rock were intersected possibly reflecting a diatreme like body that may have disrupted any earlier porphyry alteration zonation in this area. Alteration data was collected from the core using a Terraspec infrared spectrometer along with the samples for assay. No significant intervals of porphyry mineralisation were intersected however the...

Continue reading

BWR Exploration Inc. Announces a Non-Brokered Unit Offering

TORONTO, Nov. 24, 2022 (GLOBE NEWSWIRE) — BWR Exploration Inc. (TSX.V: BWR) (“BWR” or the “Company”) announces that it has initiated a non-brokered, unit offering (the “Unit Offering”) of up to 8,000,000 units (the “Units”) set out below at a price of $0.03 per Unit. Each Unit will consist of one common share (a “Common Share”) of the Company and one-half Common Share purchase warrant (a “Half Warrant”). Two Half Warrants comprise one Common Share purchase warrant (a “Full Warrant”) of the Company. Each Full Warrant will expire 36 months from the date of issue (the “Full Warrant Expiry Date”) and will entitle the holder thereof to purchase one Common Share (a “Full Warrant Share”) at a price of $0.06 per Full Warrant Share within 24 months from the closing of the Unit Offering and for the period that is for 24 months plus one day...

Continue reading

VOLT CARBON TECHNOLOGIES ANNOUNCES RESULTS OF AGM AND MANAGEMENT CHANGE

Calgary, Alberta, Canada, Nov. 24, 2022 (GLOBE NEWSWIRE) — Volt Carbon Technologies Inc. (“Volt Carbon” or the “Company”) (TSX-V: VCT) (OTCQB: TORVF) is pleased to announce that the shareholders of the Company elected six (6) directors: Dr. William Pfaffenberger, Dr. David Madill, Glen Nursey, V-Bond Lee, Dr. Zhongwei Chen and Robert Martin at its Annual General and Special Meeting of the Shareholders held on November 21, 2022 (the “Meeting”). The shareholders also approved the Company’s amended stock option plan. After careful consideration of succession planning for the future, Dr. William Pfaffenberger is resigning from the position of CEO, President, Chairman of the Board of Volt Carbon and Board Member after serving for the past 15 years. The Board of Directors has officially accepted his resignation from the Company effective...

Continue reading

Junshi Biosciences Announces Submission of a Marketing Authorization Application for Toripalimab to the UK Medicines and Healthcare Products Regulatory Agency

— 2nd MAA submission in Europe reflects toripalimab’s steady yet speedy progress towards global commercialization SHANGHAI, China, Nov. 24, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the company has submitted a marketing authorization application (“MAA”) to the United Kingdom’s Medicines and Healthcare products Regulatory Agency (“MHRA”) for toripalimab. The indications requested in the MAA are: 1) Toripalimab, in combination with cisplatin and gemcitabine, for the first-line treatment of patients with locally recurrent or metastatic nasopharyngeal carcinoma (“NPC”) and 2)Toripalimab, in combination with...

Continue reading

Change in the number of own shares held by Aktia Bank Plc

Aktia Bank PlcStock Exchange Release24 November 2022 at 14.30 p.m. Change in the number of own shares held by Aktia Bank Plc Aktia Bank Plc has today, based on a decision made by the company’s Board of Directors, divested 9,462 own shares held by the company for payment of deferred instalments in accordance with the terms of various incentive programmes to a total of 20 persons. The divestment of own shares is based on the authorisation by the Annual General Meeting of Shareholders held on 6 April 2022. After the above-mentioned divestments, a total of 230,801 shares remain in the company’s possession. Aktia Bank Plc Further information:Ari Syrjäläinen, General Counsel, tel. +358 50 362 9587 Distribution:Nasdaq Helsinki LtdMass mediawww.aktia.com Aktia is a Finnish asset manager, bank and life insurer that has been creating wealth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.